Lamin A/C-regulated cysteine catabolic flux modulates stem cell fate through epigenome reprogramming.
Saved in:
| Title: | Lamin A/C-regulated cysteine catabolic flux modulates stem cell fate through epigenome reprogramming. |
|---|---|
| Authors: | Wang Y; Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Yinuo.Wang@medma.uni-heidelberg.de.; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany. Yinuo.Wang@medma.uni-heidelberg.de., Shi H; Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Wittig J; Department of Vascular Dysfunction, ECAS, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany., Ren Y; Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Cordero J; Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany., Dewenter M; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.; Institute of Experimental Cardiology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany., Mella J; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA., Buchwalter A; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA., Backs J; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.; Institute of Experimental Cardiology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Helmholtz-Institute for Translational AngioCardioScience (HI-TAC) of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) at Heidelberg University, Heidelberg, Germany., Wieland T; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.; Experimental Pharmacology, ECAS, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Heineke J; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.; Helmholtz-Institute for Translational AngioCardioScience (HI-TAC) of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) at Heidelberg University, Heidelberg, Germany.; Department of Cardiovascular Physiology, ECAS, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Fleming I; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.; Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany., Bibli SI; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany. Iris.Bibli@medma.uni-heidelberg.de.; Department of Vascular Dysfunction, ECAS, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Iris.Bibli@medma.uni-heidelberg.de.; Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany. Iris.Bibli@medma.uni-heidelberg.de.; Helmholtz-Institute for Translational AngioCardioScience (HI-TAC) of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) at Heidelberg University, Heidelberg, Germany. Iris.Bibli@medma.uni-heidelberg.de., Dobreva G; Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Gergana.Dobreva@medma.uni-heidelberg.de.; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany. Gergana.Dobreva@medma.uni-heidelberg.de.; Helmholtz-Institute for Translational AngioCardioScience (HI-TAC) of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) at Heidelberg University, Heidelberg, Germany. Gergana.Dobreva@medma.uni-heidelberg.de. |
| Source: | Nature metabolism [Nat Metab] 2026 Feb; Vol. 8 (2), pp. 431-453. Date of Electronic Publication: 2026 Jan 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature Country of Publication: Germany NLM ID: 101736592 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2522-5812 (Electronic) Linking ISSN: 25225812 NLM ISO Abbreviation: Nat Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41606307 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lamin A/C-regulated cysteine catabolic flux modulates stem cell fate through epigenome reprogramming. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Yinuo.Wang@medma.uni-heidelberg.de.; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany. Yinuo.Wang@medma.uni-heidelberg.de.<br /><searchLink fieldCode="AU" term="%22Shi+H%22">Shi H</searchLink>; Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Wittig+J%22">Wittig J</searchLink>; Department of Vascular Dysfunction, ECAS, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Ren+Y%22">Ren Y</searchLink>; Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Cordero+J%22">Cordero J</searchLink>; Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Dewenter+M%22">Dewenter M</searchLink>; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.; Institute of Experimental Cardiology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Mella+J%22">Mella J</searchLink>; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Buchwalter+A%22">Buchwalter A</searchLink>; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Backs+J%22">Backs J</searchLink>; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.; Institute of Experimental Cardiology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Helmholtz-Institute for Translational AngioCardioScience (HI-TAC) of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) at Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wieland+T%22">Wieland T</searchLink>; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.; Experimental Pharmacology, ECAS, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Heineke+J%22">Heineke J</searchLink>; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.; Helmholtz-Institute for Translational AngioCardioScience (HI-TAC) of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) at Heidelberg University, Heidelberg, Germany.; Department of Cardiovascular Physiology, ECAS, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.<br /><searchLink fieldCode="AU" term="%22Fleming+I%22">Fleming I</searchLink>; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany.; Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Bibli+SI%22">Bibli SI</searchLink>; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany. Iris.Bibli@medma.uni-heidelberg.de.; Department of Vascular Dysfunction, ECAS, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Iris.Bibli@medma.uni-heidelberg.de.; Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany. Iris.Bibli@medma.uni-heidelberg.de.; Helmholtz-Institute for Translational AngioCardioScience (HI-TAC) of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) at Heidelberg University, Heidelberg, Germany. Iris.Bibli@medma.uni-heidelberg.de.<br /><searchLink fieldCode="AU" term="%22Dobreva+G%22">Dobreva G</searchLink>; Department of Cardiovascular Genomics and Epigenomics, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Gergana.Dobreva@medma.uni-heidelberg.de.; German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim, Germany. Gergana.Dobreva@medma.uni-heidelberg.de.; Helmholtz-Institute for Translational AngioCardioScience (HI-TAC) of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) at Heidelberg University, Heidelberg, Germany. Gergana.Dobreva@medma.uni-heidelberg.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101736592%22">Nature metabolism</searchLink> [Nat Metab] 2026 Feb; Vol. 8 (2), pp. 431-453. <i>Date of Electronic Publication: </i>2026 Jan 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101736592 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2522-5812 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225225812%22">25225812 </searchLink><i>NLM ISO Abbreviation: </i>Nat Metab <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41606307 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s42255-025-01443-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 431 Titles: – TitleFull: Lamin A/C-regulated cysteine catabolic flux modulates stem cell fate through epigenome reprogramming. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Shi H – PersonEntity: Name: NameFull: Wittig J – PersonEntity: Name: NameFull: Ren Y – PersonEntity: Name: NameFull: Cordero J – PersonEntity: Name: NameFull: Dewenter M – PersonEntity: Name: NameFull: Mella J – PersonEntity: Name: NameFull: Buchwalter A – PersonEntity: Name: NameFull: Backs J – PersonEntity: Name: NameFull: Wieland T – PersonEntity: Name: NameFull: Heineke J – PersonEntity: Name: NameFull: Fleming I – PersonEntity: Name: NameFull: Bibli SI – PersonEntity: Name: NameFull: Dobreva G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2522-5812 Numbering: – Type: volume Value: 8 – Type: issue Value: 2 Titles: – TitleFull: Nature metabolism Type: main |
| ResultId | 1 |